Imigran Recovery 50mg tablets

Country: United Kingdom

Language: English

Source: MHRA (Medicines & Healthcare Products Regulatory Agency)

Active ingredient:

Sumatriptan succinate

Available from:

Forest Laboratories UK Ltd

ATC code:

N02CC01

INN (International Name):

Sumatriptan succinate

Dosage:

50mg

Pharmaceutical form:

Oral tablet

Administration route:

Oral

Class:

No Controlled Drug Status

Prescription type:

Valid as a prescribable product

Product summary:

BNF: 04070401

Patient Information leaflet

Page 1 of 5
PACKAGE LEAFLET: INFORMATION FOR THE USER
IMIGRAN RECOVERY 50MG TABLETS
Sumatriptan
PATIENT INFORMATION LEAFLET
READ THIS LEAFLET CAREFULLY BEFORE TAKING THESE TABLETS.
REMEMBER THIS MEDICINE IS FOR YOU. Never give the tablets to someone
else, because it may harm
them, even if their symptoms seem to be the same as yours.
KEEP THIS LEAFLET - you may need to read it again. It contains
important information.
You must tell your doctor if your pharmacist has confirmed you have
migraine and if you take Imigran
Recovery.
If you have any further questions or there is anything you do not
understand, ask your doctor or
pharmacist.
Throughout this leaflet, Imigran Recovery 50mg Tablets are referred to
as Imigran Recovery.
IN THIS LEAFLET:
1.
What these tablets do
2.
Check before you take …
3.
How to take the tablets
4.
Possible side effects
5.
Storing your medicine
6.
More about the medicine
7.
More about migrane
1.
WHAT THESE TABLETS DO
Imigran Recovery is used to treat migraine. These tablets contain
sumatriptan, which belongs to a
group of medicines called triptans (_5-HT, receptor agonists_).
Migraine symptoms may be caused by
the temporary swelling of blood vessels in the head due to a temporary
imbalance in the body’s natural
chemicals.
The tablets are believed to work on this imbalance and reduce the
swelling of these blood vessels. The
tablets help to take away the headache and other symptoms of a
migraine attack such as feeling sick
(nausea) and sensitivity to light and sound. They start to relieve
migraine headache about 30 minutes
after you take them.
2.
CHECK BEFORE YOU TAKE …
DON’T TAKE IMIGRAN RECOVERY:

unless you suffer from migraines (a doctor or pharmacist needs to
confirm this)

if you are trying to prevent a migraine attack – only take it when
your migraine headache
begins

until you are sure this is a migraine and not just a headache

if you are under 18 or over 65

if you have had an allergic reaction to sumatriptan, or any of the
other ingredients in the
tablets, o

Summary of Product characteristics

OBJECT 1
IMIGRAN RECOVERY
Summary of Product Characteristics Updated 12-Jun-2014 | Forest
Laboratories UK Limited (a subsidiary
of Actavis PLC)
1. Name of the medicinal product
Imigran Recovery, 50 mg, film-coated tablets.
2. Qualitative and quantitative composition
50 mg sumatriptan base (as the succinate salt).
For excipients, see Section 6.1.
3. Pharmaceutical form
Film-coated tablet.
Pink, film-coated, triangular shaped, biconvex tablets debossed with
'GS 1YM' on one face and '50' on the
other.
4. Clinical particulars
4.1 Therapeutic indications
Imigran Recovery is indicated for the acute relief of migraine
attacks, with or without aura. Imigran
Recovery should only be used where there is a clear diagnosis of
migraine.
4.2 Posology and method of administration
ADULTS (18-65 YEARS OF AGE)
The recommended dose is a single 50 mg tablet that should be swallowed
whole with water. It is
advisable that Imigran Recovery be taken as soon as possible after the
onset of a migraine headache
although it is effective at whatever stage of the headache it is
taken.
If there is a response to the first tablet but the symptoms recur, a
second tablet may be taken. However,
this must be at least 2 hours after the first tablet. No more than two
50 mg tablets (total dose 100 mg) may
be taken in any 24 hour period or to treat the same attack.
If there is no response to the first tablet, a second tablet should
not be taken for the same attack.
CHILDREN AND ADOLESCENTS (UNDER 18 YEARS OF AGE)
Not to be used in children or adolescents under 18 years of age.
The safety and effectiveness of Imigran Recovery in children have not
been established.
ELDERLY (OVER 65 YEARS OF AGE)
Not to be used in those over 65 years of age.
Experience of the use of Imigran Recovery in patients over 65 years is
limited.
4.3 Contraindications
Imigran Recovery must not be used prophylactically.
Hypersensitivity to any component of the preparation or to
sulphonamides.
Previous myocardial infarction, or those who have ischaemic heart
disease, coronary vasospasm